Navigation Links
Genedata Screener to Present at 10th Annual Ion Channel Retreat
Date:6/25/2012

Vancouver, Canada (PRWEB) June 25, 2012

Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Genedata Screener® for Ion Channel Screening will be a featured presentation at the 10th Annual Ion Channel Retreat. The Retreat showcases new screening technologies and the importance of improving the safety of target compounds. The Genedata presentation will show how to overcome current issues in Ion Channel data analysis on real-life examples using Genedata Screener for Ion Channel Screening.

The new Genedata Screener for Ion Channel Screening is a first-in-class Ion Channel screening solution that enables scalable and automated data analysis. The software’s exceptional data loading and processing speed combined with the ability to simultaneously process multiple plates significantly reduces analysis time. Part of the Retreat’s Ion Channel Screening session, the Genedata presentation will highlight analyses of two distinct datasets from leading pharmaceutical companies that collaborate with Genedata.

Presentation Highlights
Today’s electrophysiology experiments measure simultaneously 1000s of compounds and 100,000s of data points per day, producing gigabytes of raw data – for which the data analysis renders a severe bottleneck. Genedata Screener’s streamlined data analysis workflows for microfluidics-based Automated Patch Clamp (APC) experiments increase the sample throughput and the level of detail in biological characterizations. The Genedata session will present a case study that:

  •     Overviews typical challenges in APC data analysis
  •     Discusses specific problems in uncovering relevant biological effects
  •     Demonstrates single- and multi-compound workflows that mitigate data analysis risks
  •     Provides examples on how analysis time can be reduced and result quality improved with automated analysis workflows

Genedata Screener for Ion Channel Screening easily integrates into corporate screening data analysis environments, and imports data from various well/plate instruments including Fluxion Ionflux™ and MD IonWorks® Quattro™ and Barracuda™.

“With the latest innovations in miniaturization and automation, screening instrumentation now enables parallel testing applying innovative technologies such as APC, which results in data of unprecedented volume, complexity, and value,” said Dr. Othmar Pfannes, CEO of Genedata. “With Genedata Screener for Ion Channel Screening, we enable scientists to take advantage of these technologies by empowering them to efficiently analyze and interpret this data. Our support of Automated Electrophysiology underscores the Genedata commitment to advanced screening technologies such as High Content and Label-Free screening.”

NOTE: The Genedata session --“High-volume data analysis workflows for microfluidics-based automated patch clamps” -- will be presented by Dr. Stephan Steigele on June 27 at 3:00pm EDT. To schedule a briefing email: jackie.thrasivoulos (at) genedata (dot) com.

About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US. http://www.genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Read the full story at http://www.prweb.com/releases/Ion_channel_screening/Genedata_Screener/prweb9626890.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. In Comes the Non-Toxic Rust Remover; Rusterizer Presents Its Rust Removal Product Made With Natural Ingredients
2. Dads get Present from Rusterizer, Company Marks Down its Rust Remover by 27%
3. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
4. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
5. NYSE Companies and NASDAQ Companies June 7th Investor Presentations Now Available at RetailInvestorConferences.com
6. Fusion presents low proliferation risk, experts conclude
7. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
8. Luminex Corporation to Present at Jefferies 2012 Global Healthcare Conference
9. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
10. Watson to Present at Goldman Sachs Global Healthcare Conference 2012
11. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Cancer experts from Austria, ... could be a new and helpful biomarker for malignant pleural mesothelioma. Surviving Mesothelioma ... read it now. , Biomarkers are components in the blood, tissue or ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight ... solutions to the healthcare market. The company's primary focus is on new product ... marketing strategies that are necessary to help companies efficiently bring their products to ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a range ... place between the two entities said Poloz. Speaking ... Ottawa , he pointed to the country,s inflation ... federal government. "In ... "Both institutions have common economic goals, why not sit down ...
Breaking Biology Technology:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):